NCEirish

[NCEirish @fxarb247]

@SkibumSmit @markemerritt You keep cherry picking data & repeating yourself. Here’s my MJ numbers: Bought RYM at $4, sold at $64, that’s a 1600% gain: bought OGI at .90 cents, gain TBD: & bought VFF at .95 cents, that’s a 250% gain so far. Time to get out of your mom’s basement & get a life.

[NCEirish @fxarb247]

@SkibumSmit @markemerritt Pretty defensive for a guy who mimics my key points & cherry picks financial info from AUX press releases w/o demonstrating any true depth of financial competence. As for the other LP’s, yep they all continue to destroy value even today. That should tell you something…. 🤡

[NCEirish @fxarb247]

@SkibumSmit @markemerritt Well, non-responsive to my questions. Apparently you haven’t listened to the VFF & CURA conference calls discussing dumping & price compression. You’re telling us you know more than the CEO’s do about the market? And how much AUX value destroyed with a 14:1 reverse split in July?

[NCEirish @fxarb247]

@SkibumSmit @markemerritt So, my final word: Why don’t you tell us specifically how declining margins (price compression) in AUXLY will impact the BS and, thus their ability to execute their $30m in capex.

[NCEirish @fxarb247]

@SkibumSmit @markemerritt 30 years of doing this: I’m quite sure I understand corporate income, balance sheet (BS) & cash flow (CF) statements. The comparison was to VFF & CURA, not ACB. So, if price compression persists, Auxley will not generate as much CF as expected, let alone BS impacts. Dumping…..

[NCEirish @fxarb247]

@SkibumSmit @markemerritt They can’t do it with their own cash flow/BS. EU GMP is where the margins are. Non EU GMP is an ag commodity market, subject to declining prices. VFF & CURA both said there was extensive dumping in Canada last quarter. Then you have seasonality. Call me highly skeptical.

[NCEirish @fxarb247]

@SnakeBlissken81 @catalyst_ceo WHY? Resigning CFO’s and Auditors plus a crashing stock means a big NFW. Still more uncertainty to come.

[NCEirish @fxarb247]

@markemerritt @CultivatedNews Oooops, correction, it’s was $1.8 Billion from Altria in 2018. So let’s do the math: $1.8 Billion less $800 million in current cash equals $1 Billion spent in 8 years. On what? Where’s the return? Oh right, he’s buying back shares. This is shareholder value destruction.

[NCEirish @fxarb247]

@markemerritt @CultivatedNews I love it when lawyers try to do finance. What’s the terminal value of the recent Netherlands deal just closed? Especially if the trial MJ program is not extended? How much of the $1.6 Billion in Altria money has been torched? Share Price? Not impressed by his deal skills.

[NCEirish @fxarb247]

@markemerritt @AuxlyGroup It’s clear from the VFF Q3 report that ag commodity pricing dynamics facing many US MJ corps, are happening with Canadian LP’s, given the dumping of lower quality stuff. No one is immune, but those which own more of the value chain fair better. Large Integrated LP scale wins.

[NCEirish @fxarb247]

@DittoInvest Collapsing prices in Canada, upcoming seasonal softness and potential new capex required for TX facility. It was a good report, but the market looks forward.

[NCEirish @fxarb247]

@CapitalMattkets @GMnyMny Matt, I have had extensive discussions with a former judge in the ALJ process, he happens to be a law partner of my primary attorney. What you say is total BS. Anything subject to the CSA, is subject to the ALJ process , as well as other legal avenues. Move on huckleberry.

[NCEirish @fxarb247]

@CapitalMattkets @GMnyMny S3 medical is temporary, subject to resolution of pending lawsuits. It can be reversed & all US MJ is still federally illegal. Legal briefs for S3 medical are due 17 Fed 2027 & oral arguments sometime summer 2027. Only Congress can legalize MJ. Study the ALJ process.

[NCEirish @fxarb247]

@aaronvalue @Wheatonabix BTW, to understand the leader & business model in global EU GMP production, study $VFF - they just reported earnings this am. Profitable, cash flow +, growing, US assets, Canadian based & founded/run by former US Navy pilot. Also may be a takeover target since ACB is going OGI.

[NCEirish @fxarb247]

@aaronvalue @Wheatonabix So, $30 million and 2+ years for EU GMP certification. It’s not just capex, it’s data verification & standards. Then US operators need S3 medical (FDA) complete with export rules/regulations (2028). This is continued US MJ delusion that they can just compete globally soon. NOT

[NCEirish @fxarb247]

@markemerritt @420Odysseus I find Zuanic much more unbiased, professional, better informed and competent than the “influencers” on that other channel. Of course, Pablo earns his fees in a righteous manner.

[NCEirish @fxarb247]

@markemerritt @TheDalesReport So, listen again, he did answer the dilution question, just not in your snippet. Perhaps you should ask CURA how much shareholder value they have destroyed. Keeping it honest…

[NCEirish @fxarb247]

@markemerritt @cupofcoffeecap It’s a free market, but I find much of the “analysis” is designed to sow doubt as opposed to constructive criticism. My 30 years of PE, M&A and investment tell me that OGI, CRON & VFF are the current best opportunities. This is not a turnaround nor is any of the criticism robust.